Cargando…
Bendamustine-induced nephrogenic diabetes insipidus – A case report
INTRODUCTION: In patients with relapsed or refractory lymphoma, high-dose chemoimmunotherapy with subsequent autologous hematopoietic cell transplantation (HCT) is a standard of care. Bendamustine, an alkylating agent, is used in the BeEAM (bendamustine, etoposide, cytarabine, melphalan) protocol fo...
Autores principales: | Desjardins, Audrey, Le-Nguyen, Viviane, Turgeon-Mallette, Léa, Vo, Chloé, Boudreault, Jean-Samuel, Rioux, Jean-Philippe, Feng, Xue, Veilleux, Amélie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685724/ https://www.ncbi.nlm.nih.gov/pubmed/33990157 http://dx.doi.org/10.1177/10781552211013878 |
Ejemplares similares
-
Acquired nephrogenic diabetes insipidus in a dog with leptospirosis
por: Etish, Jamie L, et al.
Publicado: (2014) -
Partial nephrogenic diabetes insipidus associated with Castleman’s disease
por: Kim, Minah, et al.
Publicado: (2019) -
Progranulin Deficient Mice Develop Nephrogenic Diabetes Insipidus
por: Hardt, Stefanie, et al.
Publicado: (2018) -
Long-term outcome in inherited nephrogenic diabetes insipidus
por: Sharma, Sonia, et al.
Publicado: (2018) -
Sevoflurane and nephrogenic diabetes insipidus on the rise: copeptin to the rescue?
por: Honore, Patrick M., et al.
Publicado: (2019)